The First Human Application of an F-18-Labeled Tryptophan Analog for PET Imaging of Cancer
Authors:
- 27 November 2023
- journal article
- research article
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 26 (1) , 29-35
Abstract
Purpose Preclinical studies showed the tryptophan analog PET radiotracer 1-(2-18F-fluoroethyl)-L-tryptophan (18F-FETrp) to accumulate in various tumors, including gliomas, and being metabolized via the immunosuppressive kynurenine pathway. In this first-in-human study, we tested the use 18F-FETrp-PET in patients with neuroendocrine and brain tumors. Procedures We applied dynamic brain imaging in patients with gliomas (n = 2) and multi-pass 3D whole-body PET scans in patients with neuroendocrine tumors (n =4). Semiquantitative analysis of organ and tumor tracer uptake was performed using standardized uptake values (SUVs). In addition, organ dosimetry was performed based on extracted time–activity curves and the OLINDA software. Results Neuroendocrine tumors showed an early peak (10-min post-injection) followed by washout. Both gliomas showed prolonged 18F-FETrp accumulation plateauing around 40 min and showing heterogeneous uptake including non-enhancing tumor regions. Biodistribution showed moderate liver uptake and fast clearance of radioactivity into the urinary bladder; the estimated effective doses were similar to other 18F-labeled radioligands. Conclusions The study provides proof-of-principle data for the safety and potential clinical value of 18F-FETrp-PET for molecular imaging of human gliomas.Keywords
All Related Versions
Funding Information
- NCI (P30CA022453)
This publication has 26 references indexed in Scilit:
- Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imagingNuclear Medicine and Biology, 2016
- N1-Fluoroalkyltryptophan Analogues: Synthesis and in vitro Study as Potential Substrates for Indoleamine 2,3-DioxygenaseACS Medicinal Chemistry Letters, 2015
- Comparison of Amino Acid Positron Emission Tomographic Radiotracers for Molecular Imaging of Primary and Metastatic Brain TumorsMolecular Imaging, 2014
- Expression of Indoleamine 2,3-Dioxygenase and Correlation With Pathological Malignancy in GliomasNeurosurgery, 2013
- Indoleamine 2,3 dioxygenase and metabolic control of immune responsesTrends in Immunology, 2013
- IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts SurvivalClinical Cancer Research, 2012
- Accurate Differentiation of Recurrent Gliomas from Radiation Injury by Kinetic Analysis of α-11C-Methyl-l-Tryptophan PETJournal of Nuclear Medicine, 2012
- Imaging Correlates of Differential Expression of Indoleamine 2,3-Dioxygenase in Human Brain TumorsMolecular Imaging and Biology, 2009
- In Vivo Uptake and Metabolism of α-[11C]Methyl-l-Tryptophan in Human Brain TumorsJournal of Cerebral Blood Flow & Metabolism, 2006
- α[C-11]Methyl-l-Tryptophan PET Maps Brain Serotonin Synthesis and Kynurenine Pathway MetabolismJournal of Cerebral Blood Flow & Metabolism, 2000